Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
about
Mediators of inflammation in polycystic ovary syndrome in relation to adiposityAtherosclerosis and infection: is the jury still not in?Unexpected protective role for Toll-like receptor 3 in the arterial wallRegulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responsesCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsCigarette Smoke Amplifies Inflammatory Response and Atherosclerosis Progression Through Activation of the H1R-TLR2/4-COX2 AxisRole of gut microbiota in the modulation of atherosclerosis-associated immune responseAdiponectin as a potential biomarker of vascular diseaseOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisChemokines and microRNAs in atherosclerosisEndothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosisLipids and the endothelium: bidirectional interactionsThe biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patientsGenetically modified mouse models for the study of nonalcoholic fatty liver diseaseNoncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammationThe SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDLS100A8 and S100A9 in cardiovascular biology and diseaseToll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findingsTrypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disordersThe Role of TLR2, TLR4, and TLR9 in the Pathogenesis of AtherosclerosisGut Microbiome and Obesity: A Plausible Explanation for ObesityInflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsPolyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial CellsLgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expressionThe protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genesA genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.Sterile inflammation: sensing and reacting to damageContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Human oral, gut, and plaque microbiota in patients with atherosclerosis.Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.Role of NOD2/CARD15 in coronary heart disease.Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degenerationAbsence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient miceIslet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK ratMyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophagesLeukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models
P2860
Q21296837-2317E25B-8EF0-4D5A-9321-50E5E638B4A0Q22241306-FE1B671F-AC1F-4342-A1C7-D7999C129E60Q24624935-E66D3E0D-B734-4701-BE35-AD1DF97506ABQ24631052-6EE96F8F-1949-4604-949E-E26150042028Q24642646-73BEB186-07FB-406A-9659-510E38591BD9Q26750725-EED117D3-152B-4924-A4BE-608170B42BDFQ26774658-E683A78A-0771-47A0-85AB-C362983FD820Q26776119-DC7F8B5A-CF00-4D38-A243-32801570A496Q26801649-F6BAF910-7AD9-42EF-B0F2-91A5E6D2F2D8Q26821925-4B5E3CEE-682B-42C6-9449-80010ED3073AQ26822962-0A7AEFE5-26D1-422E-862B-9AC2D676410DQ26852545-2CC53433-4A0F-439D-8BCC-E79E91B4C031Q26852572-682AC420-425B-4A53-AD98-C117E81A62C1Q26860086-6D763358-15B4-4377-AEFA-3DF69F3CBF16Q26862601-F730FEFE-A6D0-4F44-BFE1-9FDD5EBF0A05Q26865248-845A6108-51D6-43E2-ADD0-54C6D9401391Q26865593-FBF2EC94-D858-4D99-B84A-820DF3148F59Q26991782-C1314E17-508D-450C-95E0-B2786E6ABD3EQ27024450-31A58D2A-251D-4E1D-BBD1-1A83B53A7B6EQ27300289-FFD10872-DB29-4242-A596-9BB6CEE73830Q27304622-5C220042-CDFA-4A33-B2DC-0BD9013CD79EQ28077737-4D55976F-5FCC-428D-A987-E312109696C6Q28087145-038848D4-E002-469A-B429-CAFC6511F7E6Q28275259-751E8395-8AA1-4ED5-9D4F-1AC59161EB53Q28537901-16DBD8A8-61DF-4017-81A9-B625EE96C80FQ28550616-6EFF843C-C5DA-46F3-A686-E7F93ED873ADQ28591315-B7DB9B98-EDED-49C9-BAC0-28F55E6D8752Q28594304-2852312E-8E63-4BDC-BA1C-3C1C7481C2B7Q29417090-16A7A986-24EF-4CBF-B89A-CD49C4DF93C7Q29620014-B439082A-EF7D-4003-8781-E49E23C6DCB5Q30318502-7D72963C-BBAE-42DA-8675-2FF833F1BD92Q30319434-8EB8CC4D-36E2-47A4-A691-C91B78CC5560Q30499024-0DC6C5FE-2FEF-4BC4-A272-B3867B5B7044Q30848049-1A5FEF2B-6896-41DB-989E-75360B2002FEQ33304877-3FBF57D2-82E2-413D-8B83-B45443B018B4Q33313069-2BFD7E51-9E60-43B4-BEA3-A0DF3CA77BBCQ33479145-D57F1265-E39D-4169-8055-B7A5D44AA048Q33501717-4C3C7244-8183-4661-9453-0C6A1CCC2E73Q33552853-4F81AC7D-F2ED-4E10-8A13-5CD5CE7867B2Q33561481-1C271019-70E5-46CA-AED3-19000B60B040
P2860
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E
@en
type
label
Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E
@en
prefLabel
Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E
@en
P2093
P2860
P356
P1476
Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E
@en
P2093
Juliana Yano
Kathrin S Michelsen
Michelle H Wong
Prediman K Shah
Shizuo Akira
Terence M Doherty
Tripathi B Rajavashisth
Wenxuan Zhang
P2860
P304
10679-10684
P356
10.1073/PNAS.0403249101
P407
P50
P577
2004-07-12T00:00:00Z